HUANG DENNIS KARL 1641217 Data last updated 2024-05-11 06:58:14 -0500 US CDT

Latest Holdings

Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.


Non-derivative Transactions     CSV download

Tips: type "code_s" to show transactions with code "S".

Filing Date Transaction Date Operation Date Original Filing Reporter Relation Opr Amounta %(Owned)b ‱(SO)c Avg Prcd Account Type Full Name Code Remain Shares Outstanding (Million)e
2024-03-05 2024-03-01 2024-03-01 4 Huang Dennis Karl SEE REMARKS acq 18757.0 22.47 2.28 0.0 Direct Common Stock ULTRAGENYX PHARMACEUTICAL INC.

code_A

code  A
83472.0 thumbnail 82.11 (RARE)
2024-03-05 2024-03-01 2024-03-01 4 Huang Dennis Karl SEE REMARKS dsp 470.0 0.56 0.06 53.69 Direct Common Stock ULTRAGENYX PHARMACEUTICAL INC.

code_F

code  F
83002.0 82.11 (RARE)

Derivative Transactions

Tips: type "code_m" to show transactions with code "M".

Filing Date Transaction Date Operation Date Original Filing Reporter Relation Opr Amounta %(Owned)b ‱(SO)c Avg Prcd Account Type Full Name Code Remain Shares Outstanding (Million)e
2024-03-05 2024-03-01 2024-03-01 4 Huang Dennis Karl SEE REMARKS acq 31400.0 100.0 3.82 53.69 Direct Stock Option (Right To Buy) ULTRAGENYX PHARMACEUTICAL INC.

code_A

code  A
31400.0 82.11 (RARE)

a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)